Showing results (381-390 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|April 22, 2026
Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging for Predicting Immunotherapy Response in Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisWenbo Xie, Linmao Sun, Yumin Fu, et al.
Liver Cancer|June 18, 2026
The 2024 International Liver Transplant Society and International Liver Cancer Association Consensus Recommendations for Liver Transplantation for Liver CancerSudha Kodali, Laura Kulik, Antonio D'Alessio, et al.
Liver Cancer|June 18, 2026
Survival Benefit of Combined Systemic and Locoregional Therapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score-Matched AnalysisFan Gao, Chengxiang Guo, Yiwen Chen, et al.
Liver Cancer|July 11, 2026
Selective Conventional Transarterial Chemoembolization Using a Glass Membrane Emulsification Device in Hepatocellular Carcinoma: Multicenter Clinical Trial in JapanToshihiro Tanaka, Hiroshi Anai, Tetsuya Masada, et al.
Liver Cancer|June 26, 2026
Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of Systemic Therapies (2020-2025)Qi-Feng Chen, Song Chen, Xiongying Jiang, et al.
Liver Cancer|July 2, 2026
Transarterial Chemoembolization plus Systemic Therapy versus Transarterial Chemoembolization alone for Unresectable, Nonmetastatic Hepatocellular Carcinoma: Meta-Analysis and Trial Sequential Analysis from Randomized Controlled TrialsJiaxi Liu, Huan Zhai, Liqi Shang, et al.
Liver Cancer|July 29, 2026
Definition of Conversion Therapy and Neoadjuvant Therapy for Hepatocellular Carcinoma: A Consensus Guideline from the Japan Liver Cancer AssociationAkihiko Ichida, Ryosuke Tateishi, Etsuro Hatano, et al.
Liver Cancer|July 29, 2026
Dissecting the Transcriptomic Profile of CD163+ Macrophages in Hepatocellular Carcinoma with VETC+ Angiogenesis Provides Potential Targets of TreatmentCamilla De Carlo, Anna Rita Putignano, Reha Akpinar, et al.
Liver Cancer|July 24, 2026
Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter StudyMasayuki Ueno, Yung-Yeh Su, Atsushi Takai, et al.
Liver Cancer|August 14, 2026
Exposure to Poly- and Perfluoroalkyl Substances and Risk of Hepatocellular Carcinoma in Male Patients with Cirrhosis Related to Hepatitis C Virus InfectionAaron P Thrift, Noura Abdulrahman, Priya B Shetty, et al.
Pageof 55